By Emilie Heidemann, Wisconsin State Journal
A Madison startup developing a way to reduce the time it takes to bring medicines to market — which could significantly mitigate the next big pandemic — has received a $2.3 million investment to move into a larger space.
Immuto Scientific, founded in 2018, has created a quicker, cheaper and more precise method to map out the structures of proteins, which can help develop treatments for cancer as well as pathogens such as SARS-CoV-2, the virus that causes COVID-19, said startup co-founder and CEO Faraz Choudhury.
Traditional methods for analyzing proteins are complex and take up to a year, and the process of making drugs that actually reach the market can span a decade. But customers using the Immuto method can get an accurate snapshot of a protein in two to three weeks, he said.